首页> 外文期刊>Kidney international. >Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura|[sol]|hemolytic-uremic syndrome (TTP|[sol]|HUS)
【24h】

Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura|[sol]|hemolytic-uremic syndrome (TTP|[sol]|HUS)

机译:血栓性血小板减少性紫癜| [sol] |溶血尿毒综合征(TTP | [sol] | HUS)中的两个新型ADAMTS13基因突变

获取原文
           

摘要

Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).BackgroundThrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) are now considered to be variants of one single syndrome called thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS). Key features are thrombocytopenia, hemolytic anemia, and subsequently impaired function of different organs, especially the kidneys and the central nervous system (CNS). One possible reason is the deficiency of von Willebrand factor-cleaving protease (vWF-CP) resulting in persistence of uncleaved, ultralarge von Willebrand factor multimers (ULvWFM).
机译:血栓性血小板减少性紫癜/溶血性尿毒症综合征(TTP / HUS)中有两个新的ADAMTS13基因突变。背景-尿毒症综合征(TTP / HUS)。关键特征是血小板减少症,溶血性贫血以及随后不同器官,特别是肾脏和中枢神经系统(CNS)的功能受损。一种可能的原因是缺乏von Willebrand因子裂解蛋白酶(vWF-CP),导致未裂解的超大型von Willebrand因子多聚体(ULvWFM)持续存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号